COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 3045: Articles 30441-30450  | Next

COVID-19 in Canada: Predictions for the future and control lessons from Asia
Christian, C., Christian, F.
10.1101/2020.03.21.20040667 — Posted: 2020-03-27
The Effect of Large-Scale Anti-Contagion Policies on the Coronavirus (COVID-19) Pandemic
Hsiang, S., Allen, D., Bell, K., Bolliger, I., Annan-Phan, S., Chong, T., Druckenmiller, H., Hultgren, A., Huang, L. Y., Krasovich, E., Lau, P., Lee, J., Rolf, E., Tseng, J., Wu, T.
10.1101/2020.03.22.20040642 — Posted: 2020-03-27
Serological diagnostic kit of SARS-CoV-2 antibodies using CHO-expressed full-length SARS-CoV-2 S1 proteins
Zhao, R., Li, M., Song, H., Chen, J., Ren, W., Feng, Y., Song, J.-W., Peng, Y., Su, B., Guo, X., Wang, Y., Chen, J., Li, J., Sun, H., Bai, Z., Cao, W. J., Zhu, J., Zhang, Q., Sun, Y., Sun, S., Mao, X., Su, J., Chen, H., He, A., Jin, R., Sun, L.
10.1101/2020.03.26.20042184 — Posted: 2020-03-27
Clinical Characteristics Hospitalized Patients with SARS-Cov-2 and HBV Co-infection
Chen, X., Jiang, Q., Ma, Z., Ling, J., Hu, W., Cao, Q., Mo, P., Yang, R., Gao, S., Gui, X., Xiong, Y., Li, J., Zhang, Y.
10.1101/2020.03.23.20040733 — Posted: 2020-03-27 Discussion: Onsite
History of Coronary Heart Disease Increases the Mortality Rate of Coronavirus Disease 2019 (COVID-19) Patients: A Nested Case-Control Study Based on Publicly Reported Confirmed Cases in Mainland China
Gu, T., Chu, Q., Yu, Z., Fa, B., Li, A., Xu, L., Wu, R., He, Y.
10.1101/2020.03.23.20041848 — Posted: 2020-03-27
Multiple-Input Deep Convolutional Neural Network Model for COVID-19 Forecasting in China
Huang, C.-J., Chen, Y.-H., Ma, Y., Kuo, P.-H.
10.1101/2020.03.23.20041608 — Posted: 2020-03-27
Evaluation of COVID-19 RT-qPCR test in multi-sample pools
Yelin, I., Aharony, N., Shaer-Tamar, E., Argoetti, A., Messer, E., Berenbaum, D., Shafran, E., Kuzli, A., Gandali, N., Hashimshony, T., Mandel-Gutfreund, Y., Halberthal, M., Geffen, Y., Szwarcwort-Cohen, M., Kishony, R.
10.1101/2020.03.26.20039438 — Posted: 2020-03-27 Discussion: Onsite
Core Outcome Set for Traditional Chinese and Western Medicine Clinical Trials of COVID-19
Qiu, R., Zhao, C., Liang, T., Hao, X., Huang, Y., Zhang, X., Chen, Z., Wei, X., Zhao, M., Zhong, C., Hu, J., Li, M., Han, S., He, T., Chen, J., Shang, H.
10.1101/2020.03.23.20041533 — Posted: 2020-03-27
World governments should protect their population from COVID-19 pandemic using Italy and Lombardy as precursor
Supino, M., d'Onofrio, A., Luongo, F., Occhipinti, G., Dal Co, A.
10.1101/2020.03.25.20042713 — Posted: 2020-03-27
Reproducibility and reporting practices in COVID-19 preprint manuscripts
Sumner, J. Q., Haynes, L., Nathan, S., Hudson-Vitale, C., McIntosh, L. D.
10.1101/2020.03.24.20042796 — Posted: 2020-03-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).